A detailed history of Transform Wealth, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Transform Wealth, LLC holds 24,009 shares of VRTX stock, worth $11.4 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
24,009
Previous 23,479 2.26%
Holding current value
$11.4 Million
Previous $11 Million 1.46%
% of portfolio
0.76%
Previous 0.84%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$460.0 - $505.78 $243,800 - $268,063
530 Added 2.26%
24,009 $11.2 Million
Q2 2024

Jul 15, 2024

BUY
$392.81 - $485.53 $153,195 - $189,356
390 Added 1.69%
23,479 $11 Million
Q1 2024

Apr 15, 2024

BUY
$407.69 - $446.08 $310,659 - $339,912
762 Added 3.41%
23,089 $9.65 Million
Q4 2023

Jan 18, 2024

BUY
$343.0 - $410.68 $105,644 - $126,489
308 Added 1.4%
22,327 $9.08 Million
Q3 2023

Oct 10, 2023

BUY
$338.18 - $362.46 $28,745 - $30,809
85 Added 0.39%
22,019 $7.66 Million
Q2 2023

Jul 13, 2023

SELL
$314.42 - $351.91 $59,739 - $66,862
-190 Reduced 0.86%
21,934 $7.72 Million
Q1 2023

Apr 14, 2023

SELL
$283.23 - $323.1 $28,889 - $32,956
-102 Reduced 0.46%
22,124 $6.97 Million
Q4 2022

Jan 12, 2023

BUY
$285.76 - $321.48 $1.58 Million - $1.78 Million
5,530 Added 33.12%
22,226 $0
Q3 2022

Oct 21, 2022

BUY
$273.83 - $305.53 $410,471 - $457,989
1,499 Added 9.86%
16,696 $4.83 Million
Q2 2022

Jul 15, 2022

BUY
$234.96 - $292.55 $3.57 Million - $4.45 Million
15,197 New
15,197 $4.28 Million
Q2 2021

Jul 20, 2021

SELL
$187.49 - $221.1 $2.25 Million - $2.65 Million
-11,985 Closed
0 $0
Q1 2021

Apr 22, 2021

BUY
$207.02 - $241.31 $180,314 - $210,181
871 Added 7.84%
11,985 $2.58 Million
Q4 2020

Jan 20, 2021

BUY
$207.01 - $276.09 $2.3 Million - $3.07 Million
11,114 New
11,114 $2.63 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Transform Wealth, LLC Portfolio

Follow Transform Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transform Wealth, LLC with notifications on news.